Milken Institute report sites strength in income-generating licenses.
Backing comes from Canadian company in medical cannabis market.
The medtech company paid for BarioSurg and its Gastric Vest System through a mix of stock and $2 million in cash.
Terms and conditions of the purchase were not made public.
The company lost $7.4 million on nominal revenue.
Medtech’s move follows hires of locally based CEO and CFO.
Series B round will boost its sales and marketing.
The heart devices will be the first on the market to offer such a feature.
The medtech company’s flagship product is used to treat extreme bone fractures.